<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>24342015</identifier>
<setSpec>1578-8989</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Oriol, Albert</dc:author>
<dc:author>Motlló, Cristina</dc:author>
<dc:description xml:lang="en">Progress in the treatment of multiple myeloma in the last decade has been able to delay, but ultimately not to prevent, the development of resistances and most patients still die of the disease or its related complications. New drugs have been developed including new alkylating agents, proteasome inhibitors and immunomodulators but also monoclonal antibodies and drugs with new mechanisms of action. Hopefully, this new generation of targeted agents will improve the results of the initial therapy, avoid relapses and development of resistances and provide better and less toxic options for the relapsed and refractory patient.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:subject>Terapias dirigidas</dc:subject>
<dc:subject>New drugs</dc:subject>
<dc:subject>Targeted therapy</dc:subject>
<dc:subject>Mieloma múltiple</dc:subject>
<dc:subject>Multiple myeloma</dc:subject>
<dc:subject>Nuevos fármacos</dc:subject>
<dc:date>2014 Sep 15 </dc:date>
<dc:title xml:lang="es">Nuevos fármacos en el tratamiento del mieloma múltiple.</dc:title>
<dc:title xml:lang="en">[New drugs in the treatment of multiple myeloma].</dc:title>
<dc:publisher>Medicina clinica</dc:publisher>
</metadata>
</record>
</pubmed-document>
